
SOTS 2nd Hour: Eli Lilly Shares Slim Down, Chip on Trump’s Shoulder, Exclusive: ConocoPhillips CEO 8/7/25
Squawk on the Street
00:00
Eli Lilly's Weight Loss Pill Setback
This chapter explores the significant drop in Eli Lilly's stock due to underwhelming data on its new obesity treatment pill, which showed lower weight loss results than anticipated. The discussion also covers the implications of these findings for market performance and future presentations of trial results.
Transcript
Play full episode